Access Resources
4301 - 4310 of 7562 Results
Title
Year
-
RESTRICTEDTitle: The Discovery of LRRK2 Mutations as a Cause of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 551End Page: 554Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27999Citation Count: 5
- Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRI2020RESTRICTEDTitle: Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRIJournal Name: PainPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 161Issue #: 6Start Page: 1255End Page: 1263Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1097/j.pain.0000000000001829Best OA location URL: https://journals.lww.com/pain/Fulltext/2020/06000/Brain_perfusion_patterns_are_altered_in_chronic.13.aspxCitation Count: 17
- LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis2020RESTRICTEDTitle: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.51071Best OA location URL: https://doi.org/10.7554/elife.51071Citation Count: 76
-
RESTRICTEDTitle: Pathology‐Proven Corticobasal Degeneration Presenting as Richardson's SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12900Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12900Citation Count: 6
- Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa2020RESTRICTEDTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://doi.org/10.1155/2020/9716317Citation Count: 8
-
RESTRICTEDTitle: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-59414-4Best OA location URL: https://www.nature.com/articles/s41598-020-59414-4.pdfCitation Count: 52
-
RESTRICTEDTitle: Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 87Issue #: 4Start Page: 584End Page: 598Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25687Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025046Citation Count: 38
- Relationship of Movement Disorders Society–Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease2020RESTRICTEDTitle: Relationship of Movement Disorders Society–Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 279End Page: 283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12902Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12902Citation Count: 5
- The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 51Issue #: 12Start Page: 2412End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14679Citation Count: 12
-
RESTRICTEDTitle: Diagnosis and Treatment of Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 323Issue #: 6Start Page: 548End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2019.22360Citation Count: 1413